These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34009433)

  • 1. Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8
    Miyazaki K; Morine Y; Imura S; Ikemoto T; Saito Y; Yamada S; Tokuda K; Okikawa S; Yamashita S; Oya T; Tsuneyama K; Shimada M
    Surg Today; 2021 Dec; 51(12):1985-1995. PubMed ID: 34009433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma.
    Yugawa K; Itoh S; Yoshizumi T; Morinaga A; Iseda N; Toshima T; Harada N; Kohashi K; Oda Y; Mori M
    Int J Clin Oncol; 2021 Oct; 26(10):1901-1910. PubMed ID: 34117554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal tumor-infiltrating lymphocytes level as a prognostic factor for resected intrahepatic cholangiocarcinoma and its prediction by apparent diffusion coefficient.
    Miyazaki K; Morine Y; Yamada S; Saito Y; Tokuda K; Okikawa S; Yamashita S; Oya T; Ikemoto T; Imura S; Hu H; Morioka H; Tsuneyama K; Shimada M
    Int J Clin Oncol; 2021 Dec; 26(12):2265-2274. PubMed ID: 34596803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
    Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
    Front Immunol; 2021; 12():705378. PubMed ID: 34526987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative monocyte-to-lymphocyte ratio as a prognosis predictor after curative hepatectomy for intrahepatic cholangiocarcinoma.
    Tao BF; Zhu HQ; Qi LN; Zhong JH; Mai RY; Ma L
    BMC Cancer; 2024 Sep; 24(1):1179. PubMed ID: 39333901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes.
    Yugawa K; Itoh S; Yoshizumi T; Iseda N; Tomiyama T; Toshima T; Harada N; Kohashi K; Oda Y; Mori M
    Mod Pathol; 2021 Apr; 34(4):798-807. PubMed ID: 33077921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblast senescence and its relation with tumour-infiltrating lymphocytes and PD-L1 expressions in intrahepatic cholangiocarcinoma.
    Lan C; Kitano Y; Yamashita YI; Yamao T; Kajiyama K; Yoshizumi T; Fukuzawa K; Sugimachi K; Ikeda Y; Takamori H; Miyanari N; Hirota M; Baba H
    Br J Cancer; 2022 Feb; 126(2):219-227. PubMed ID: 34616011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion.
    Ye Y; Zhou L; Xie X; Jiang G; Xie H; Zheng S
    J Surg Oncol; 2009 Nov; 100(6):500-4. PubMed ID: 19697355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.
    Jing CY; Fu YP; Yi Y; Zhang MX; Zheng SS; Huang JL; Gan W; Xu X; Lin JJ; Zhang J; Qiu SJ; Zhang BH
    J Immunother Cancer; 2019 Mar; 7(1):77. PubMed ID: 30885276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma.
    Ito T; Shinkawa H; Takemura S; Tanaka S; Nishioka T; Miyazaki T; Ishihara A; Kubo S
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2373-2379. PubMed ID: 32856868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte-C-reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort study.
    Lu LH; Zhong C; Wei W; Li SH; Mei J; Zou JW; Guo RP; Zhang YF
    Liver Int; 2021 Feb; 41(2):378-387. PubMed ID: 32562336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
    Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
    World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of stromal tumor-infiltrating lymphocytes in intrahepatic cholangiocarcinoma: a population-based study.
    Qiang Z; Dai K; He Y; Yang Z; Tao L; Zhang H; Yu H
    Scand J Gastroenterol; 2022 Aug; 57(8):965-971. PubMed ID: 35522155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery.
    Vigano L; Soldani C; Franceschini B; Cimino M; Lleo A; Donadon M; Roncalli M; Aghemo A; Di Tommaso L; Torzilli G
    J Gastrointest Surg; 2019 Nov; 23(11):2216-2224. PubMed ID: 30843133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy.
    Lim YJ; Koh J; Kim K; Chie EK; Kim B; Lee KB; Jang JY; Kim SW; Oh DY; Bang YJ; Ha SW
    Radiother Oncol; 2015 Oct; 117(1):165-70. PubMed ID: 26235847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High C-reactive protein/albumin ratio associated with reduced survival due to advanced stage of intrahepatic cholangiocarcinoma.
    Kano H; Midorikawa Y; Song P; Nakayama H; Moriguchi M; Higaki T; Tsuji S; Takayama T
    Biosci Trends; 2020 Sep; 14(4):304-309. PubMed ID: 32507777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
    Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
    Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predict the effect of the number of positive preoperative serum tumor markers on the surgical method and prognosis of intrahepatic cholangiocarcinoma patients based on mediation analysis].
    Li ZL; Chen JL; Tang Y; Qin DL; Chen C; Qiu YH; Wu H; He Y; Mao XH; Zhai WL; Li JD; Liang X; Sun CD; Ma K; Geng ZM; Tang ZH; Quan ZW
    Zhonghua Wai Ke Za Zhi; 2024 Jul; 62(7):685-696. PubMed ID: 38808436
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma.
    Kitano Y; Okabe H; Yamashita YI; Nakagawa S; Saito Y; Umezaki N; Tsukamoto M; Yamao T; Yamamura K; Arima K; Kaida T; Miyata T; Mima K; Imai K; Hashimoto D; Komohara Y; Chikamoto A; Ishiko T; Baba H
    Br J Cancer; 2018 Jan; 118(2):171-180. PubMed ID: 29123259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer.
    Song DH; Cho IK; Shin DW; Lee JC; Cho JY; Yoon YS; Hwang JH; Han HS; Kim J
    Surg Today; 2021 Jun; 51(6):978-985. PubMed ID: 33387024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.